Cargando…

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma

SIMPLE SUMMARY: This study aimed to evaluate the clinicopathologic significance of CD73 expression in patients with papillary thyroid carcinoma (PTC) and the potential for CD73 to serve as a therapeutic target of PTC. CD73 was highly expressed in PTC, but not in the normal thyroid tissue. Overexpres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Young Mun, Cho, Haejin, Kim, Tae-Min, Kim, Yourha, Jeon, Sora, Bychkov, Andrey, Jung, Chan Kwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603384/ https://www.ncbi.nlm.nih.gov/pubmed/33086655 http://dx.doi.org/10.3390/cancers12103042

Ejemplares similares

Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma
por: Oh, Eun Ji, et al.
Publicado: (2020)

Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma
por: Kim, Yourha, et al.
Publicado: (2017)

CCND1 Splice Variant as A Novel Diagnostic and Predictive Biomarker for Thyroid Cancer
por: Jeon, Sora, et al.
Publicado: (2018)

CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas
por: Monteiro, Inês, et al.
Publicado: (2021)

Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes
por: Kim, Kyuryung, et al.
Publicado: (2018)

Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
por: Bae, Ja-Seong, et al.
Publicado: (2014)

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology
por: Bychkov, Andrey, et al.
Publicado: (2018)

VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer
por: Choden, Sonam, et al.
Publicado: (2020)

Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation
por: Bae, Ja Seong, et al.
Publicado: (2016)

Impact of Multifocality on the Recurrence of Papillary Thyroid Carcinoma
por: Woo, Joohyun, et al.
Publicado: (2021)

Prognostic parameters for recurrence of papillary thyroid microcarcinoma
por: Kim, Tae Yong, et al.
Publicado: (2008)

Bilaterality as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma
por: Kim, Hyeji, et al.
Publicado: (2023)

Emerging Biomarkers in Thyroid Practice and Research
por: Agarwal, Shipra, et al.
Publicado: (2021)

Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
por: Jeon, Min Ji, et al.
Publicado: (2016)

Evaluation of Human MSCs Treatment Frequency on Airway Inflammation in a Mouse Model of Acute Asthma
por: Hur, Jung, et al.
Publicado: (2020)

Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter?
por: Kim, Hyeji, et al.
Publicado: (2022)

Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer
por: Lee, Seul Gi, et al.
Publicado: (2016)

Aberrant Expression of COT Is Related to Recurrence of Papillary Thyroid Cancer
por: Lee, Jandee, et al.
Publicado: (2015)

VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma
por: Choi, June Young, et al.
Publicado: (2017)

Pathologic Spectrum of Lymphocytic Infiltration and Recurrence of Papillary Thyroid Carcinoma
por: Kim, Hyun Gi, et al.
Publicado: (2014)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Tumor Sprouting in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Recurrence
por: Lee, Eunjung, et al.
Publicado: (2014)

Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach
por: Jung, Chan Kwon, et al.
Publicado: (2022)

Solitary Skin Metastasis of Papillary Thyroid Carcinoma
por: Kwon, Hyemi, et al.
Publicado: (2014)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study
por: Kim, Mijin, et al.
Publicado: (2021)

Overexpressed TP73 induces apoptosis in medulloblastoma
por: Castellino, Robert C, et al.
Publicado: (2007)

The indices of body size and aggressiveness of papillary thyroid carcinoma
por: Kim, Ju-Yeon, et al.
Publicado: (2011)

The role of adjuvant radiation therapy for locoregionally recurrent papillary thyroid carcinoma
por: Hwang, Hyun, et al.
Publicado: (2021)

Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age
por: Cho, Jin-Kyu, et al.
Publicado: (2012)

The Use of Fine-Needle Aspiration (FNA) Cytology in Patients with Thyroid Nodules in Asia: A Brief Overview of Studies from the Working Group of Asian Thyroid FNA Cytology
por: Jung, Chan Kwon, et al.
Publicado: (2017)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

Relationship of PPARG overexpression with prognostic parameters in papillary thyroid carcinoma
por: Asya, Orhan, et al.
Publicado: (2022)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Clinicopathological features of recurrent papillary thyroid cancer
por: Zhu, Jian, et al.
Publicado: (2015)

The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis
por: Li, Xin, et al.
Publicado: (2020)

Papillary thyroid carcinoma with thyroiditis: lymph node metastasis, complications
por: Kim, Yon Seon, et al.
Publicado: (2013)

Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration
por: Oh, Hoon Kyu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qgf3ma562sj55c85gvu3i44qkm